Newsmeme!
Discover News you didn't know existed
Genta Incorporated announced that it has received $2.8 million in non-dilutive cash proceeds from the sale of net operating tax losses and research tax credits generated in prior tax years as part of the Technology Business Tax Certificate Program sponsored by the New Jersey Economic Development Authority (NJEDA), pursuant to the rules, regulations and stipulations set forth by the program.
Investigators at New Jersey's only NCI-designated Comprehensive Cancer Center have launched a clinical trial targeting immunotherapy. Scientists are testing a series of vaccine injections, including those given directly into the tumor, to see if they will produce an immune response against pancreatic cancer.
Celsion Corporation announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Fred Hutchinson Cancer Research Center to Evaluate Homspera(R) in Novel Cancer Therapy Model; Expand on Previous Homspera Findings in the Domain of Cancer Immunotherapy
SCOTTSDALE, AZ--(Marketwire - 02/10/10) - ImmuneRegen BioSciences Inc., a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTC.BB: IRBS - News ), today announced the execution of an agreement with Fred Hutchinson Cancer Research Center to commence studies utilizing ImmuneRegen's Homspera. Under the agreement the Hutchinson Center will perform exploratory studies on Homspera, specifically ...
Helicobacter pylori (H. pylori) is the causal agent of chronic gastritis, ulcer and gastric cancer. It has the potential to persist in the human stomach for decades, sometimes causing neither harm nor clinical symptoms. Nevertheless, on some occasions, depending on the host immune system and the strain causing the infection, the outcome can be very serious. To maintain the infection, the ...
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation. Similar to ...
Dendreon will have three plants to make its Provenge prostate cancer drug by mid-2011, said Chief Executive Officer Mitchell Gold.
Doctors' concerns cover postpartum depression, vaccine status and smoking cessation, trying to provide the healthiest environment for babies.
Doctors' concerns cover postpartum depression, vaccine status and smoking cesssation.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |